NKGen Biotech amends AlpineBrook loan deal, adds USD 2.42 million secured convertible note

NKGen Biotech, Inc.

NKGen Biotech, Inc.

NKGN

0.00
  • NKGen Biotech entered a Third Omnibus Amendment with AlpineBrook Capital GP I Limited on May 27, 2026.
  • Amendment adds a USD 2.42 million secured convertible loan, including a USD 220,000 facilitation fee; net proceeds USD 2.2 million.
  • Additional Note #3 converts into common stock at USD 0.08 per share, subject to adjustment.
  • Consideration shares increased to 12,953,947 shares, scheduled for delivery in six installments over 30 months from the loan closing.
  • Issued Additional Warrant #3 with a 10-year term, USD 0.08 exercise price, 9.99% ownership cap; size tied to three times the note principal.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nkgen Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-064294), on June 02, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.